wire crossing technique in antegrade approach · wire crossing technique in antegrade approach 5th...
TRANSCRIPT
Toyohashi Heart Center
Takahiko Suzuki MD
Wire Crossing Technique in Wire Crossing Technique in Antegrade approachAntegrade approach
55thth CTO Live 2011CTO Live 2011
Development of CTO wires and CCT activities
Conquest
SHOOTING
1995 1999 2003
Magic
Miracle
2005 2006
FielderFCX-tream
Mid Japan CCIC CCT
CTO club
Live course(Osaka, Toyohashi, Shiga)
ACS Standard
USCI Steerable
CTO-PCI in Antegrade approach Current Choice of CTO wires
Fielder FC
X-treme
Miracle
Conquest
11stst
22ndnd
FinalFinal
Wizard
Development of CTO wire techniques and our activities
Single wire
IVUS guided
2000 2001 2005
Retrograde (CART)
Parallel wire
2010
Mid Japan CCIC CCT
19991994 1995
CTO Club
Principle of wire crossing technique strategy
Single wire technique with Plastic Jacket WiresSingle wire technique with Plastic Jacket Wires
Retrograde wire techniqueCART or reverse CART
Parallel wire technique
IVUS guided wiringIVUS guided wiring
Antegrade approachAntegrade approach
Are there any good collateral channels from retrograde?
YesNo
IVUS Guide Technique is Final option
Single wire technique Single wire technique with plastic jacket wireswith plastic jacket wires
Retrograde / CART Retrograde / CART
Parallel wiringParallel wiring×××
IVUS Guide Wiring TechniqueIVUS Guide Wiring Technique○
Tactics of the Parallel wire technique
• A first wire should be advanced to the mid or distal segment of CTO lesion in the subintima.
• Miracle 12g or 6g is preferred as a second wire.• A second wire should be turned to the opposite or
different direction of a first wire which already entered in the subintimal space.
• A first wire is more likely to enter in the subintimal space at the CTO entry, but it is sometime to enter in mid or distal CTO. Hence, the operator should prudently handle the first wire and check the entry point of the subintima by feeling of the guide wire.
Limitations of the Parallel Wire Technique
• The second wire should be advanced into a different direction which the first wire was assumed entering in the subintimal space. However, the wire is often prevented to advance in the true lumen due to wire bias.• Continuing this wire manipulation tends to enlarge the false lumen causing difficulty in the IVUS-guided technique.
Tactics of the IVUS-guided technique
• Initially, a first wire is advanced into the distal of a totally occluded lesion. Then, a false lumen is dilated with a 1.25mm or 1.5mm balloon catheter to insert an IVUS catheter .
• IVUS imaging is used to identify a CTO entry thereby detecting the position of a second wire tip. The drilling or penetration technique is used to advance into the true lumen of the total occlusion.
Toyohashi Heart Center
IVUS Guide Technique Overview
A B
C D
E
How to advance the guidewire under the IVUS-guidance
Guide wire rarely advances through the center of the true lumen of a totally occluded lesion despite it successfully enters to the CTO entry.In most cases, the wire is easily advanced along the
edge of the vessel and then into false lumen.Under this circumstance, the guide wire should not be
pushed . Instead, the guide wire is gently advanced to the center of the occlusion with torque control.
Toyohashi Heart Center
Even under the IVUS-guidance, it’s difficult to enter a second wire with strong bending distal tip . If the presence of the following conditions is met.
1) large dissection2) wire bias 3) vessel bending4) hard plaque
Limitations of the IVUS-guided technique
Toyohashi ExperienceToyohashi Experience
CTO-PCI
~~~~2010
Lesion Characteristics(’99-’10, n=1724)
Target vesselRCA 673 (39.0%)LAD 517 (30.0%)LCX 368 (21.3%)LMT 8 (0.5%)Branch 138 (8.0%)
Bypass graft 2 (0.12%)Prior PCI 476 (27.6%)In-stent occlusion 193 (11.2%)Bending>45°°°° 261 (15.2%)Calcified lesion 627 (36.4%)Significant side branch 254 (14.7%)
Number of CTO-PCI (’02~’10 n=1271)
(n)
Initial Success Rate
73.5%(83/113)
79.0%(94/119)
84.2%(117/139)
(%)
86.3%(145/168)
92.4%(157/170)
87.6% (1113/1271)
92.2%(142/154)
91.6%(142/155)
91.5%(108/118)
92.6%(125/135)
Successful guide wire technique by year (’02~’10)
Crossing Techniques(2010, n=135)
Crossing Guide Wire(2010, n=135)
Success rate of guide wire crossing
86.3%(120/139)
95.6%(129/135)
Toyohashi experienceCTO-PCI (’04 vs. ’10)
Crossed guide wires
67.5%
15.0%
17.5%
33.5%
65%
1.5%
(n=120) (n=129)
Toyohashi experienceCTO-PCI (’04 vs. ’10)
(n=120) (n=129)
Successful guide wire technique by year
Toyohashi experienceCTO-PCI (’04 vs. ’10)
55.7%
9.3%
20.0%
1.4%
61.5%
4.4%
10.4%
16.3%
3.0%
Complications (’99~’10)Major complications
– Death in hospital 9 (0.5%)– Emergency CABG 7 (0.3%)– Q-MI 5 (0.3%)
Minor complications– Cardiac tamponade 16 (0.9%)– Aortic dissection 5 (0.3%)– Acute occlusion 12 (0.7%)– Subacute occlusion 4 (0.2%)– Side branch compromise 53(3.1%)– Coronary perforation
• Type-I 160 (9.3%)• Type-II 16 (0.9%)
Angiographic Follow UpBMS era DES era
(Jan.’03-Sep.’04) (Jan.’08-Dec.’9)
No. of CTOs 227 276Initial success 183 (80.6%) 249(90.2%)
No. of CAG F/U 139 (76.0%) 158 (63.0%)
No. of restenosis 54 (38.8%) 41(29.5%)No. of reocclusion 23 (16.5%) 19 (12.0%)
77 (55.3%) 60 (30.1%)No. of TLR 60 (43.1%) 46(29.1%)
Clinical restenosis 29.5% 24.1%Clinical TLR 32.8% 18.5%
Mean F/U period 7.1±±±±4.4(mos.) 9.3±±±±4.9(mos.)
Summary
・・・・From Toyohashi Heart Center experience in 2010, antegrade approach was 80% of recanalized CTO.
・・・・Comparing 2004 with 2010 , plastic jacket wire was used more frequently (from 15% to 65%) in successful CTO -PCI. On the other hand , the usage of spring coil wire was decreased from 68% to 34%.
Conclusion
• Antegrade approach is a basic technique in CTO-PCI.
• Antegrade wiring should be a first strategy for all CTO cases even though in case with suitable collateral channels for retrograde approach from donor artery .
• IVUS guide wiring is final option in CTO-PCI . Operator should perform procedure with this point in mind .
1313thth CTO Club CTO Club
June 17-18, 2011, Toyohashi, Japan
www.cct.gr.jp/ctoclubwww.cct.gr.jp/ctoclub
See you in Kobe!
Thank you for your attention. Thank you for your attention.
Baseline DemographicsVariablesVariables CTO SuccessCTO Success
N=791N=791
CTO FailureCTO Failure
N=113N=113
P valueP value
Age, yrs, mean+/Age, yrs, mean+/--SDSD 65.42+/65.42+/--10.710.7 66.01+/66.01+/--11.211.2 0.5870.587
MaleMale 654(82.2%)654(82.2%) 94(83.2%)94(83.2%) 0.8370.837
Diabetes MellitusDiabetes Mellitus 318(40.2%)318(40.2%) 42(37.4%)42(37.4%) 0.4730.473
HypertensionHypertension 312(61.7%)312(61.7%) 74(65.5%)74(65.5%) 0.3340.334
HyperlipedemiaHyperlipedemia 312(39.5%)312(39.5%) 45(39.9%)45(39.9%) 0.9360.936
Previous MIPrevious MI 679(85.8%)679(85.8%) 99(87.6%)99(87.6%) 0.5710.571
Previous CABGPrevious CABG 94(11.1%)94(11.1%) 20(17.7%)20(17.7%) 0.0360.036
Previous PCIPrevious PCI 220(27.9%)220(27.9%) 27(24.1%)27(24.1%) 0.2930.293
Unstable AnginaUnstable Angina 60(7.7%)60(7.7%) 15(12.8%)15(12.8%) 0.0260.026
CCS Class 3/4CCS Class 3/4 52(6.6%)52(6.6%) 11(9.3%)11(9.3%) 0.1870.187
Vessel desVessel des-- Single Vs DsSingle Vs Ds
Two Vs DsTwo Vs Ds
Three Vs DsThree Vs Ds
102(12.9%)102(12.9%)
258(32.6%)258(32.6%)
431(54.5%)431(54.5%)
7(6.4%7(6.4%
35(31.03%)35(31.03%)
70(62.5%)70(62.5%)
0.0050.005
J.Am.Coll Cordeiol.Intv.2009:2:489-497
Angiographic VariablesVariablesVariables CTO SuccessCTO Success
N=791N=791
CTO FailureCTO Failure
N=113N=113
P valueP value
Target vesselTarget vessel-- LADLAD
RCARCA
LCXLCX
LMTLMT
BranchBranch
RITA/SVGRITA/SVG
239(30.2%)239(30.2%)
312(39.3%)312(39.3%)
182(23.1%)182(23.1%)
4(0.4%)4(0.4%)
52(6.6%)52(6.6%)
2(0.2%)2(0.2%)
28(24.6%)28(24.6%)
43(37.9%)43(37.9%)
19(17.2%)19(17.2%)
1(0.4%)1(0.4%)
22(19.7%)22(19.7%)
0(0%)0(0%)
<0.0001<0.0001
Side branch at CTO siteSide branch at CTO site 144(18.2%)144(18.2%) 11(9.8%)11(9.8%) 0.030.03
CalcificationCalcification--ModerateModerate
SevereSevere
214(26.9%)214(26.9%)
79(9.9%)79(9.9%)
22(19.2%)22(19.2%)
22(19.2%)22(19.2%) 0.0010.001
Non Aortic ostialNon Aortic ostial 86(10.9%)86(10.9%) 17(14.7%)17(14.7%) 0.2940.294
In Stent RestenosisIn Stent Restenosis 95(12.1%)95(12.1%) 9(8.3%)9(8.3%) 0.1740.174
TortuousityTortuousity-- ModerateModerate
SevereSevere
81(10.5%)81(10.5%)
35(4.4%)35(4.4%)
16(14.3%)16(14.3%)
12(10.3%)12(10.3%)
0.0010.001
J.Am.Coll Cordeiol.Intv.2009:2:489-497
In-Hospital ComplicationsVariableVariable CTO Success=791CTO Success=791 CTO Failure=113CTO Failure=113 P ValueP Value
DeathDeath 2(0.25%)2(0.25%) 3(2.6%)3(2.6%)
Q wave MIQ wave MI 4(0.50%)4(0.50%) 1(0.88%)1(0.88%)
Non Q MINon Q MI 20(2.5%)20(2.5%) 2(1.76%)2(1.76%)
Acute Repeat PCIAcute Repeat PCI 5(0.6%)5(0.6%) 0(0%)0(0%)
Urgent CABGUrgent CABG 1(0.10%)1(0.10%) 1(0.88%)1(0.88%)
MACEMACE 12(1.5%)12(1.5%) 5(4.4%)5(4.4%) 0.0270.027
Aortic DissectionAortic Dissection 1(0.10%)1(0.10%) 1(0.88%)1(0.88%) nsns
Delayed tamponadeDelayed tamponade 5(0.6%)5(0.6%) 1(0.88%)1(0.88%) nsns
Distal EmbolisationDistal Embolisation 24(3.0%)24(3.0%) 0(0%)0(0%) 0.0080.008
SpasmSpasm 2(0.23%)2(0.23%) 0(0%)0(0%) 1.001.00
Any DissectionAny Dissection 110(13.9%)110(13.9%) 25(22%)25(22%) 0.0060.006
Side branch compromiseSide branch compromise 35(4.4%)35(4.4%) 1(0.88%)1(0.88%) 0.0080.008
Sub acute occlusionSub acute occlusion 2(0.23%)2(0.23%) 0(0%)0(0%) 1.001.00
J.Am.Coll Cordeiol.Intv.2009:2:489-497
Logistic regression for procedural failure
VariablesVariables Hazard ratioHazard ratio 95% C.I95% C.I P ValueP Value
Female sexFemale sex 0.930.93 .57.57--1.521.52 0.7870.787
AgeAge 0.980.98 0.970.97--1.01.0 0.1640.164
Diabetes MellitusDiabetes Mellitus 1.081.08 0.780.78--1.511.51 0.6280.628
Previous MIPrevious MI 0.810.81 0.500.50--1.341.34 0.4270.427
Previous CABGPrevious CABG 0.740.74 0.430.43--1.051.05 0.1950.195
Unstable anginaUnstable angina 0.610.61 0.360.36--1.061.06 0.0840.084
InIn--stent restent re--stenosisstenosis 1.271.27 0.650.65--2.492.49 0.4780.478
Absence of side branchAbsence of side branch 1.961.96 1.181.18--3.263.26 0.0090.009
Severe TortuousitySevere Tortuousity 2.302.30 1.261.26--4.184.18 0.0060.006
Moderate CalcificationModerate Calcification 1.951.95 1.191.19--3.213.21 0.0080.008
Severe CalcificationSevere Calcification 1.601.60 0.970.97--2.652.65 0.0640.064
Ostial locationOstial location 0.700.70 0.440.44--1.111.11 0.1320.132
Multi vessel diseaseMulti vessel disease 1.201.20 0.850.85--1.691.69 0.2830.283
J.Am.Coll Cordeiol.Intv.2009:2:489-497
Baseline Demographics
Retro
Success vs. Failure
p=ns
Circ Cardiovasc Intervent 2009:2:124-132
Angiographic Variables
Retro
Success vs. Failure
p=ns
Circ Cardiovasc Intervent 2009:2:124-132
Collateral Channels
CC00or01
CC<90°P<0.0001
Circ Cardiovasc Intervent 2009:2:124-132